Correlation Between Verrica Pharmaceuticals and Carmell Therapeutics
Can any of the company-specific risk be diversified away by investing in both Verrica Pharmaceuticals and Carmell Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verrica Pharmaceuticals and Carmell Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verrica Pharmaceuticals and Carmell Therapeutics, you can compare the effects of market volatilities on Verrica Pharmaceuticals and Carmell Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verrica Pharmaceuticals with a short position of Carmell Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verrica Pharmaceuticals and Carmell Therapeutics.
Diversification Opportunities for Verrica Pharmaceuticals and Carmell Therapeutics
0.81 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Verrica and Carmell is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Verrica Pharmaceuticals and Carmell Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Carmell Therapeutics and Verrica Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verrica Pharmaceuticals are associated (or correlated) with Carmell Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Carmell Therapeutics has no effect on the direction of Verrica Pharmaceuticals i.e., Verrica Pharmaceuticals and Carmell Therapeutics go up and down completely randomly.
Pair Corralation between Verrica Pharmaceuticals and Carmell Therapeutics
Given the investment horizon of 90 days Verrica Pharmaceuticals is expected to generate 1.65 times more return on investment than Carmell Therapeutics. However, Verrica Pharmaceuticals is 1.65 times more volatile than Carmell Therapeutics. It trades about -0.02 of its potential returns per unit of risk. Carmell Therapeutics is currently generating about -0.09 per unit of risk. If you would invest 160.00 in Verrica Pharmaceuticals on August 31, 2024 and sell it today you would lose (36.00) from holding Verrica Pharmaceuticals or give up 22.5% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Verrica Pharmaceuticals vs. Carmell Therapeutics
Performance |
| Timeline |
| Verrica Pharmaceuticals |
| Carmell Therapeutics |
Verrica Pharmaceuticals and Carmell Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Verrica Pharmaceuticals and Carmell Therapeutics
The main advantage of trading using opposite Verrica Pharmaceuticals and Carmell Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verrica Pharmaceuticals position performs unexpectedly, Carmell Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Carmell Therapeutics will offset losses from the drop in Carmell Therapeutics' long position.| Verrica Pharmaceuticals vs. Cue Biopharma | Verrica Pharmaceuticals vs. Eliem Therapeutics | Verrica Pharmaceuticals vs. Inhibrx | Verrica Pharmaceuticals vs. Molecular Partners AG |
| Carmell Therapeutics vs. ZyVersa Therapeutics | Carmell Therapeutics vs. Sonnet Biotherapeutics Holdings | Carmell Therapeutics vs. Revelation Biosciences | Carmell Therapeutics vs. Quoin Pharmaceuticals Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |